Reversing Resistance - Development of Novel Combination Chemotherapy Approaches to Combat Drug Resistance in Ovarian Cancer

StatusActive
Effective start/end date2/09/191/09/22

Funding

  • (M00109.0001/TZH/JGC): £84,097.00